MTOR and primary cutaneous T-cell non-Hodgkin lymphoma: The ERK-1/2 and PI3K/Akt/mTOR pathways downstream of cytokine signaling cross-talk among themselves and may work together synergistically in the TME of CTCL (38, 69, 92–95).